Superficial thrombophlebitis – diagnostics and treatment
Authors:
V. Štvrtinová 1; A. Dukát 2; M. Frankovičová 3; P. Kubisz 5; P. Labaš 1; D. Mištuna 6; J. Radoňak 6; V. Šefránek 3; M. Šimaljaková 4
Authors‘ workplace:
Slovenská angiologická spoločnosť Slovenskej lekárskej spoločnosti, predsedkyňa prof. MUDr. Viera Štvrtinová, CSc.
1; Slovenská internistická spoločnosť Slovenskej lekárskej spoločnosti, predseda prof. MUDr. Andrej Dukát, CSc.
2; Slovenská spoločnosť pre cievnu chirurgiu Slovenskej lekárskej spoločnosti, predseda prof. MUDr. Vladimír Šefránek, CSc.
3; Slovenská dermatovenerologická spoločnosť Slovenskej lekárskej spoločnosti, podpredsedkyňa prof. MUDr. Mária Šimaljaková, CSc. 5Slovenská spoločnosť pre hemostázu a trombózu Slovenskej lekárskej spoločnosti, predseda prof. MUDr. Peter Kubisz, DrSc.
4; Slovenská chirurgická spoločnosť Slovenskej lekárskej spoločnosti, vedecký sekretár doc. MUDr. Dušan Mištuna, CSc., mim. prof.
6
Published in:
Vnitř Lék 2009; 55(2): 131-135
Category:
Guidelines
Overview
Superficial thrombophlebitis (ST) is a common disease, usually considered benign. However, the practice of systemic duplex ultrasonography has revealed a large number of deep-vein thromboses concomitant with ST. In contrast with extensive information on the management of deep vein thrombosis, little is known about the most appropriate treatment of the ST. Systematic duplex ultrasonography investigation has been proposed in the initial management of ST, to detect the presence of any underlying deep vein thrombosis. Because ST may extend into the deep venous system and potentially engender pulmonary embolism, treatment with low-molecular-weight-heparins might be the best choice. In our work diagnostic and therapeutic procedures for ST, proposed by Slovak angiological society, Slovak society for vascular surgeons, Slovak dermatological society, Slovak society for haemostasis and thrombosis, Slovak surgical society and Slovak internistic society are discussed.
Key words:
superficial thrombophlebitis – diagnosis – treatment
Sources
1. Leon L, Giannoukas AD, Dodd D et al. Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg 2005; 29: 10–17.
2. Gillet JL, Allaert FA, Perrin M. Superficial thrombophlebitis in non varicose veins of the lower limbs. A prospective analysis in 42 patients. J Mal Vasc 2004; 29: 263–272.
3. Sarica-Kucukoglu R, Akdag-Kose A, Kayabal IM et al. Vascular involvement in Behcet’s disease: a retrospective analysis of 2319 cases. Int J Dermatol 2006; 45: 919–921.
4. Ramelet AA, Perrin M, Kern P et al. Phlebology. 5th ed. Elsevier Masson SAS 2008.
5. Puchmayer V, Roztočil K. Praktická angiologie. Praha: Triton 2000.
6. Ramelet AA, Kern P, Perrin M. Varicose veins and telangiectasias. Paris: Elsevier 2004.
7. Prandoni S, Tormene D, Pesavento R et al. High vs low doses of low molecular weight heparin for the treatment of superficial vein thrombosis of the legs: a double blind, randomized trial. J Thromb Haemostas 2005; 3: 1152–1157.
8. Di Nisio M, Middeldorp S, Wichers I. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev 2007; 24: CD004982.
9. Górski G, Szopinski P, Michalak J et al. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis. Angiology 2005; 56: 9–17.
10. Blättler W, Schwarzenbach B, Largiader J. Superficial vein thrombophlebitis – serious concern or much ado about little? VASA 2008; 37: 31–38.
11. Štvrtinová V. Povrchová tromboflebitída. In: Štvrtinová V (ed). Choroby ciev. Bratislava: SAP 2008, 727–730.
12. Hirsch J. Guidelines for antithrombotic therapy. Hamilton: BC Decker Inc 2008.
13. De Maeseneer MGR. Superficial thrombophlebitis of the lower limb: Practical recommendations for diagnosis and treatment. Acta chir belg 2005; 105: 57–61.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2009 Issue 2
Most read in this issue
- Superficial thrombophlebitis – diagnostics and treatment
- Guidelines for duplex ultrasound exam of limb veins
- Aortic valve sparing operations and reconstruction – from anatomy to the long‑term results
- The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension